IL-16 effects on A549 lung epithelial cells: dependence on CD9 as an IL-16 receptor?
Yadav
Santosh
S
Department of Environmental Health Sciences, School of Public Health and Tropical Medicine, Tulane University New Orleans, LA, USA.
Shi
Yongli
Y
Wang
He
H
D019138:Antibodies, Blocking / Q000494:pharmacology; D015703:Antigens, CD / Q000276:immunology / Q000378:metabolism*; D017209:Apoptosis / Q000187:drug effects; D053148:Caspase 3 / Q000378:metabolism; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D004847:Epithelial Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D005786:Gene Expression Regulation; D006801:Humans; D019410:Interleukin-16 / Q000494:pharmacology*; D008168:Lung / Q000473:pathology; D008562:Membrane Glycoproteins / Q000276:immunology / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism; D053721:Receptors, Interleukin-16 / Q000276:immunology / Q000378:metabolism*; D060245:Tetraspanin 29
D019138:Antibodies, Blocking; D015703:Antigens, CD; C554869:CD9 protein, human; D019410:Interleukin-16; D008562:Membrane Glycoproteins; D019253:Proto-Oncogene Proteins c-bcl-2; D053721:Receptors, Interleukin-16; D060245:Tetraspanin 29; D053148:Caspase 3